Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen Doberstein Insider Profile
4 Followers
Stephen Doberstein, SVP & Chief Scientific Officer at Nektar Therapeutics, holds 3.33K shares in Dicerna Pharma (Ticker: DRNA), holds 107.67K shares in Nektar Therapeutics (Ticker: NKTR), holds ― shares in Forte Biosciences (Ticker: FBRX).
Stephen Doberstein Nektar Therapeutics (NKTR)SVP & Chief Scientific Officer
Nektar Therapeutics (NKTR)
SVP & Chief Scientific Officer
Ranked #96,247 out of 98,564 Corporate Insiders
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-160.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen Doberstein holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stephen Doberstein
Stephen Doberstein's Trading History
Nektar Therapeutics
Sep 09, 2019
SVP & Chief Scientific Officer
Informative Buy
259.20K
$152.89K
Dicerna Pharma
Jun 07, 2021
―
Uninformative Buy
―
$127.39K
Forte Biosciences
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Stephen Doberstein's performance on stock
You May Also Like
Stephen Doberstein insider profile FAQ
What is the percentage of profitable transactions made by Stephen Doberstein?
The percentage of profitable transactions made by Stephen Doberstein is 20%.
What is the average return per transaction made by Stephen Doberstein?
The average return per transaction made by Stephen Doberstein is -160.20%.
What stocks does Stephen Doberstein hold?
Stephen Doberstein holds: NKTR, DRNA, FBRX stocks.
What was Stephen Doberstein’s latest transaction?
Stephen Doberstein latest transaction was an Uninformative Buy of ―.
What was Stephen Doberstein's most profitable transaction?
Stephen Doberstein’s most profitable transaction was an Informative Buy of NKTR stock on September 9, 2019. The return on the trade was 5.50%.
What is Stephen Doberstein's role in Nektar Therapeutics?
Stephen Doberstein's role in Nektar Therapeutics is SVP & Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.